Ask to take part

Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.

Contact Information:

Mr Erlick Pereira
epereira@sgul.ac.uk


Alex Alamri
aalamri@sgul.ac.uk


Study Location:

Skip to Main Content
English | Cymraeg
Be Part of Research - Trial Details - Cingulotomy for refractory neural pain after spinal cord injury v1.0

Cingulotomy for refractory neural pain after spinal cord injury v1.0

Recruiting

Open to: Female / Male

Age: 18 Years - 70 Years

Medical Conditions

Injuries to unspecified part of trunk, limb or body region


This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.


Neuropathic pain is a common long-term problem following a spinal cord injury. Studies show that chronic pain has a significant detrimental impact on an individual’s quality of life, ability to manage their daily activities and emotional well-being. Despite treatment by pain specialists, there remains a proportion of patients with refractory pain for whom there are no more options.
We propose to determine whether a procedure called cingulotomy, in essence the cutting of targeted brain pathways involved in regulating chronic pain, could help these most difficult to treat cases. This procedure is a form of stereotactic neurosurgery, which is able to target a specific region of interest in the brain with submillimetre accuracy. A thin wire is guided carefully to the target, the tip of which is then heated by radio-waves to cause a small, focal lesion (area of damage), and thus in effect cut the relevant overactive nerve pathways.
The safety and efficacy of this procedure has been established in a number of different causes of neuropathic pain, but there remains only limited evidence of its use in spinal cord injury. We aim to establish if this is safe and effective in this group of patients.

Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.  

The recruitment start and end dates are as follows:

29 Dec 2021 30 Apr 2025

Observational and Interventional

Type: Active Monitoring;



You can take part if:



You may not be able to take part if:


Traumatic brain injury Severe cognitive impairment Significant medical co-morbidity (e.g. coagulopathy) Radiofrequency lesioning or MRI incompatible device (e.g. baclofen pump or spinal cord stimulator) already in situ


Below are the locations for where you can take part in the trial. Please note that not all sites may be open.

  • St George's Hospital (tooting)
    Blackshaw Road
    London
    Greater London
    SW17 0QT

Alex Alamri
aalamri@sgul.ac.uk


Mr Erlick Pereira
epereira@sgul.ac.uk



The study is sponsored by St. George's Hospital Medical School and funded by STOKE MANDEVILLE SPINAL RESEARCH .




We'd like your feedback

Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.


Is this study information helpful?

What will you do next?

Read full details

for Trial ID: CPMS 49541

Last updated 13 May 2025

This page is to help you find out about a research study and if you may be able to take part

You can print or share the study information with your GP/healthcare provider or contact the research team directly.